Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care

29Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim: To describe the journey of patients with metastatic castration-resistant prostate cancer (mCRPC) in treatment with radium-223. Methods: A multiperspective analysis was performed using narrative medicine in four Italian centers. Results: The substantial impact of mCRPC on quality of life through all phases of the disease was described. After an initial lack of awareness of the disease or denial of its effects, symptoms of pain, fatigue and side effects often led to sadness, fear and loneliness. The majority underwent radium-223 therapy positively, restoring their quality of life and routine activities. Conclusion: Using narrative medicine, the importance of a patient-centered approach in the pathway of care for patients with mCRPC through all the stages of the disease was highlighted.

Cite

CITATION STYLE

APA

De Vincentis, G., Monari, F., Baldari, S., Salgarello, M., Frantellizzi, V., Salvi, E., … Cortesi, E. (2018). Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care. Future Oncology, 14(27), 2821–2832. https://doi.org/10.2217/fon-2018-0318

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free